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We feel that we have bcen able to clarify
to some extent the nature of cantharidin acanthol-
ysis. This work follows as a natural sequence
previous work on blister formation and
acantholysis by one of the authors (1, 2, 3) as
well as the observations of Epstein and Kligman
(4) that cantharidin acantholysis will take place
in explants of human skin incubated in serum
at 37° C.
We have been able to show that the in vitro
acantholysis is probably enzymatic in nature.
The enzymatic mechanism of acantholysis
induced by cantharidin has some interesting
characteristics, among which are strict heat
dependence, denaturation by freezing or ex-
posure to fixatives, inhibition by heavy metals
and arsenoxide, as well as other sulfhydryl
binding agents. Also this in vitro acantholysis
can be inhibited by hydrocortisone and a number
of other disparate agents. The acantholytie
potential of cantharidin is quite stable, being
resistant to excessive thermal exposures, ex-
traction with organic solvents, ageing and the
constant environmental insults of laboratory
handling and storage.
It has been known for over 2000 years that
products of a certain beetle (canthous vesicaloria,
or its relatives) will induce blister formation in
human skin after topical application. These prod-
ucts (cantharides) or a refined derivative (can-
tharidin) have been used sporadically for many
years in therapy, diagnosis and basic investigation
of some human diseases. In the time of Hippocrates,
this agent was used for the treatment of dropsy.
The compound is widely and erroneously known
as an aphrodasiac. The agent is excreted in the
urine and in its passage through the urethra may
initiate severe urethritis with a coincident se-
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verely painful erection. A recent report concerns
two fatal cases of cantharidin poisoning which
were induced by a young man who offered two
young ladies coconut ice impregnated with can-
tharidin. This report (5) in addition to others (6,
7) makes it quite clear that cantharidin is a potent
epithelial toxin with widespread systemic effects,
that it can be absorbed through the gastrointes-
tinal tract, and that remarkably small doses may
be fatal.
A review of the autopsy reports in cantharidin
poisoning impresses one because of the lack of
detail of epithelial cell damage. Rather, the em-
phasis is on ulceration, necrosis, edema, hemor-
rhage, etc., without any description of the subtle
but definite and characteristic epithelial changes
induced by cantharidin.
Epstein very recently pointed out that can-
tharidin induces a primary acantholytic reaction
which will proceed in vitro in serum if one uses ex-
plants of human skin (4). It has been shown that
acantholytic reactions in human skin can be in-
duced in vitro by 3—6 M. urea, 75% lithium bro-
mide, mild thermal damage, disulfide-splitting
agents and Borate buffer above pH 8.5 (1, 2, 3).
In general, cantharidin has been considered as
a type of primary irritant which induces an ec-
zema-like picture clinically and histologically and
has, in fact, been used as a model to show subtle
histologic differences between allergic contact
dermatitis and primary irritant contact derma-
titis (8, 9).
A recent article suggests the use of eantharidin
for treatment of verrucae vulgares because of the
extensive epithelial damage induced by can-
tharidin as compared to the minimal damage to
the corium (10).
There is no work extant, to our knowledge,
which suggests that eantharidin induces an en-
zymatic acantholysis.
MATERIALS AND METHODS
Fresh human skin was used for most experi-
ments. This was obtained from surgery (breast
and leg amputations) one to five hours before
use. The skin was cut into 20 mm2 pieces with a
razor blade. Cantharidin powder was applied
to the epidermal surface and the piece of skin
put into a humid Petri dish. The Petri dish was
incubated at 4° C., 20° C., 25° C., and 37° C.
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Agents injected into coriom before
topical cantharidin*
Concen-
tration
Acanthol-
ysis
1. Cholesterol 1/50 0
2. Hydrocortisone acetate... 1/250 0
3. Prednisolone P04 1/250 0
4. Prednisolone acetate 1/250 0
5. Medrol suceinate 1/500 0
6. Diisopropylfluorophos-
phate 1/100 0
7. Propyl & methyl paraben. 1/1000 0
8. CuSO4 1/500 0
9. HgCI2 1/500 0
10. AgN03 1/500 0
11. As0a 1/10,000 0
12. N-Ethyl maleimide 1/10,000 0
13. lodoacetic acid 1/1000 0
14. Ethyl thiosulfinate 1/10,000 0
15. Butyl thiosulfinate 1/10,000 0
16. DDD reagent 1/100 +
17. Bennet's reagent 1/100 +
18. Heparin 1/100 +
19. Chondroitin 804 1/100 +
20. Hyaluronic acid 1/100 +
21. Ovomucoid 1/100 +
22. Desoxyribonucleie acid... 1/100 +
23. Ribonucleic acid 1/100 +
24. Soy bean trypsin inhib-
itor 1/100 +
25. Human serum as is +
26. Gamma globulin as is +
27. Suramin sodiom 1/100 +
* 0.1 cc. of a mixture of agent in 0.1 M. tris
buffer pH 7.0 injected into the corium and can-
tharidin applied topically before incubation.
for 30 minutes to 20 hours. The skin was then
removed and fixed in formalin for routine stains.
A few special histochemical stains were done.
Adult and baby rat skin were treated in the
same way.
In order to test inhibitors of the cantharidin-
induced acantholysis, various agents were in-
jected into the corium just before the specimens
were incubated. It was determined that tris
buffer pH 7.0—7.4, 0.1—0.01 M. did not influence
the histologic picture after incubation so this
diluent was used for almost all the compounds
tested for inhibitory activity. About 0.1—0.3 cc.
were injected into the corium with a 26-gauge
needle and tuberculin syringe. The enzymes
tested for acantholytic activity were also in-
corporated into tris buffer as above and injected
into the corium. No cantharidin was applied
Enzy,nes injected into corium (no
cantharidin)*t
Concen-
tration
Acanthol-
ysis
mgns/cc
1. Papain 1 +
2. Elastase 1 +
3. Trypsin 1 0
4. Lipase 1 0
5. b-glucuronidase 1 0
6. Desoxyribonuclease 2 0
7. Ribonuclease (pancre-
atic) 2 0
8. b-glucosidase 2 0
9. Lysozyme 2 0
10. Hyaluronidase 2 0
11. Carboxypeptidase 2 0
* 0.1 cc. of a mixture of the enzyme in 0.1 and
0.01 M. tris buffer pH 7.0 and 7.4 injected into
the corium.
t Al] enzymes were obtained in the purest forms
commercially available.
when various test enzymes were injected. All
enzymes used were the most pure that were
available commercially. *
The steroids that were injected were also in
pure form.t
Fresh skin which had been frozen for 2—60 days
was tested for cantharidin acantholysis. Also,
fresh skin was treated with solid CO2 for 2
minutes and then allowed to thaw before can-
tharidin application. Whole pieces of skin and 6u
sections of skin that had been treated separately
with formalin, 80% alcohol and acetone were
also treated with cantharidin.
Various buffers (citrate, barbiturate, acetate,
phosphate, and tris) were tested alone, by in-
jection, and by immersion of skin into these
buffers for periods of 2—20 hours at 37° C. This
covered a pH range from 3.0—8.6 and molarity
from 0.1—0.01. In the absence of cantharidin
only citrate pH 3.0 and phosphate pH 7.0—7.4
buffers induced acantholysis. The latter induced
this acantholysis sporadically and its morphology
was quite different from that induced by can-
tharidin.
A detailed listing of agents used in this study
is presented in Tables I and II.
We also separated the epidermis from fresh
human skin by stretching and scraping (11).
* Supplied by Worthington Biochemical Co.
and Sigma Co.
t Supplied by IJphohn Co. and Schering Co.
TABLE I TABLE II
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The epidermis thus removed was incubated
with cantharidin in a humid atmosphere at 37° C.
for 20 hours. Also freshly separated epidermis
was dusted with cantharidin and reapplied to
the corium from which it had been separated.
The fragments of epidermis thus spread out over
the corium and dusted with cantharidin were
incubated at 37° C. in a humid Petri dish. The
epithelium from the cornea of the ox eye was
treated in an identical manner, i.e. with clean
separation and reapplication to the stroma of
the cornea before incubation with cantharidin.
Epidermis alone and whole human skin was
extracted before and after cantharidin acanthoiy
sis. The extracts were examined for sulfhydryl
groups and amino groups (12, 13).
RESULTS
Cantharidin powder applied topically to
fresh human skin in vitro will provoke acantholysis
when incubated at 37° C. in a humid Petri dish.
Incubation at 20—25° C. and 4° C. for periods
up to 48 hours will not create any evidence of
acantholysis. The acantholysis observed at 37° C.
with cantharidin begins within 30 minutes and
is usually complete in 2—4 hours. (See Figs. 1
and 2.) Acantholysis can be elicited in rat skin
by the same technic.
If skin is frozen, even for periods of less than
2 minutes, cantharidin will not provoke acanthol-
ysis. If the skin is exposed to alcohol, formalin
or acetone previous to cantharidin application,
acantholysis will not take place. If the epidermis
is mechanically- scraped from the corium with a
- scalpel it becomes immune to cantharidin acan-
tholysis even if it is reapplied to cantharidin-
treated corium. Also, cuts through the upper
third of the corium will render this top layer
(epidermis + top of corium) immune to
-acantholysis. --Similar behavior was shown for
FIG. 1. Fresh human skin incubated with cantharidin at 37° C. for two hours
'. .—-
4,4 ,'Tj
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Fin. 2. Fresh human skin. Ethyithiosulfinate 1/10,000injected into corium and incubated with can-
tharidin for two hours at 37° C.
cornea! epithelium of the ox eye. This epithelium
undergoes acantholysis when cantharidin is
applied to the intact cornea but when the corneal
epithelium is removed, no acantholysis will
take place in the separated epithelium.
Next it was shown that intradermal injection
of 0.1 cc. of 1/500 concentrations of Ag,
Cu, and 1/10,000 concentrations of arsenoxide
would completely inhibit cantharidin acan-
tholysis. (See Figure 2.) Control injections of
the buffer alone did not interfere with acantholy-
sis. Agents such as iodoacetic acid, N-ethyl
maleimide, and ethylthiosulfinate, which are
rather specific sulfhydryl binding agents, will
completely inhibit cantharidin acantholysis. A
number of other agents were shown to inhibit
cantharidin acantholysis when injected into the
corium. (See Table I.) It was demonstrated
that the sulfhydryl binding agents will inhibit
the acantholysis if they are injected before or
within 30 minutes after 37° C. incubation with
cantharidin.
Measurement of sulfhydryl groups and amino
groups present in human skin (epidermis and
whole skin) before and after eantharidin acan-
tholysis failed to reveal any significant change.
The acantholytic properties of cantharidin
are not altered by autoclaving or boiling can-
tharidin for 30 minutes before its application to
skin.
The histologic picture of in vitro cantharidin
acantholysis involves a subtle disappearance of
intercellular bridges and slight separation of
epidermal cells early in the reaction. Later the
cytoplasm becomes less well stained and more
granular as the cell separation becomes more
complete. Histochemical observations using
P.A.S., toluidine blue, and DDD reagent (14)
did not reveal any significant findings.
A collection of mucolytic and proteolytic
enzymes was tested by intradermal injection in
fresh skin and subsequent incubation for 2—20
hours at 37° C. (See Table II.) Of all those
tested only papain and elastase will induce
acantholysis. In each instance the morphology
of the cells is very different from cantharidin
acantholysis and the proteolytic acantholysis
also differs from cantharidin acantholysis in
respect to the agents which will inhibit or not
inhibit their acantholytic activity.
It was curious that, sporadically, 0.1 M.
phosphate buffer pH 7.0—7.4 would induce
acantholysis in fresh skin. After a few unfortunate
early experiences with this buffer, tris buffer
was used almost exclusively. Tris buffer did not
on any occasion induce acantholysis by itself,
NATURE OF CANTHARIDIN ACANTHOLYSIS 291
either on injection or immersion of the fresh
skin at 37° C. for periods up to 20 hours. Citrate
buffer pH 3.0, 0.1 M. and borate buffer 0.1 pH
8.5 will also induce acantholysis. The other
buffers used did not induce acantholysis in any
of many experiments.
DISCUSSION
Our work indicates quite definitely that
cantharidin releases an enzymatic acantholytic
factor(s) within the skin. This enzymatic process
may well be related, if not identical, to that
released in human skin by mild thermal damage
(2). Certainly the morphologic and chemical
characteristics of the acantholysis induced by
these seemingly different agents (cantharidin
and thermal damage) have a great deal in com-
mon.
One would suspect that a proteolytic or perhaps
a disulfide splitting enzyme would account for
the acantholysis (1, 2) but chemical analysis of
treated skin suggested that neither proteolysis
nor sulfhydryl liberation had been a significant
chemical event.
The question of how cantharidin liberates
this enzymatic acantholysis seems to be com-
pletely mysterious. We have no observations
which would suggest even a theory at this time.
The observations of acantholytic action in-
duced by elastase and papain are quite interesting
even if it is probable that these enzymes are not
involved in cantharidin acantholysis. In vim
studies with these enzymes would merit at-
tention.
Inhibition of cantharidin acantholysis by pure
preparations of such steroids as hydrocortisone,
Medrol® and Prednisolone® was of interest
because of the possible relationship to treatment
of acantholytic diseases. The concentrations
needed to inhibit the effect of heavy doses of
cantharidin is beyond that which could be
easily given except by intradermal injection.
The very small amounts of arsenoxide needed to
totally inhibit cantharidin acantholysis suggest a
basis for the old method of treatment for pemphi-
gus vulgaris with Fowler's solution.
One of the most encouraging aspects of this
study is that we have a splendid model to study
acantholysis and endogenous factors within the
skin which are capable of inducing breakdown
of epidermal cells.
This appears to be an excellent example of a
toxic agent inducing release of an enzymatic
reaction in a specific area of an organ. In this
case the liberated enzymatic process goes on to
alter the epidermal cells in such a way that
vesication and blister formation result. The
acantholysis provoked is almost indistinguishable
from that seen in acantholytic skin diseases
such as pemphigus vulgaris, Hailey and Hailey's
disease, and Darier's disease as well as experi-
mental acantholysis induced by disulfide splitting
agents, 3—6 M. urea, and mild thermal damage.
The first obvious question is whether or not a
number of unrelated etiologic agents might pro-
voke in a given cell a common reaction (en-
zymatic cytolysis). This is certainly in con-
sonance with present concepts in the pathogenesis
of disease; i.e. that there are a few basic pathologic
reactions in tissue and that multiple agents may
induce any one of them.
The next logical step seemed to us to be the
extraction of the acantholytic factor(s) from
cantharidin treated skin. We are now involved
in experiments to accomplish this.
A recent article by Weber (15) suggests that a
specific transaminase is increased in the blister
fluid of cantharidin induced blisters. It is unde-
termined what role, if any, this enzyme might
play in development of the acantholysis.
SUMMARY
(1) Cantharidin induces an enzymatic acan-
tholysis in human and rat skin.
(2) The acantholytic factor(s) come from the
skin itself.
(3) The acantholytic enzyme(s) appear to be
sulfhydryl dependent and can be inhibited by a
variety of seemingly unrelated compounds
including hydrocortisone and its relatives.
(4) Pretreatment of skin by freezing, acetone,
alcohol, or formalin destroys the acantholytic
potential induced by cantharidin.
(5) Epidermis scraped free from the corium,
or attached to only a part of the upper corium,
will not undergo acantholysis.
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DISCUSSION
DE. HERMANN PINKu5 (Monroe, Michigan):
What is the relationship of your results to Dr.
Brennan's work some years ago when he used
cantharidin as a diagnostic agent in pemphigus?
DE. FRANCIs A. ELLIS (Baltimore, Md.):
I understand that the treatment of paronychial
warts with cantharidin is very useful because
the cantharidin causes acantholysis of the wart
cells. Although this report is basically a research
report, I wonder if Dr. Stoughton has had any
experience with the treatment of paronychial
warts with this drug. I think Dr. Kligman has
suggested previously this mode of therapy for
essentially the same reason.
DR. HERMAN BEEEMAN (Philadelphia, Penna):
Dr. Stoughton, how do you explain Dr. O'Brien's
production of acantholysis on his own skin by
hypertonic salt solution?
DE. RICHARD B. STOUGHTON (in closing): As
for the treatment of paronychial warts with
cantharidin, I have not had much personal ex-
perience. We have had some experience with
warts in other locations and I think it has worked
fairly well, although we see a few recurrences,
as we have seen with other methods of therapy.
As far as the induction of acantholysis with
hypertonic solutions, Dr. Beerman, I am not
acquainted with such work and I cannot make
any comment on it.
